Drug intelligence / Profile preview

punicic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Punicic acid is a conjugated linolenic acid (CLnA) and an omega-5 polyunsaturated fatty acid primarily derived from pomegranate seed oil (*Punica granatum*). It is recognized for its diverse pharmacological properties, including potent antioxidant, anti-inflammatory, and anticancer activities. In oncology, punicic acid has demonstrated the ability to selectively impair ovarian cancer cell viability by inducing ferroptosis and mitochondrial dysfunction while sparing normal cells. It also acts as a potential sensitizer for cisplatin therapy. Beyond cancer, it is investigated for its role in managing metabolic disorders such as obesity and diabetes, improving lipid profiles, and providing cardiovascular protection. Mechanistically, it may interact with peroxisome proliferator-activated receptors (PPARs) and modulate lipid metabolism pathways.

Other names
(9Z,11E,13Z)-octadeca-9,11,13-trienoic acidtrichosanic acidomega-5 conjugated linolenic acidomega5 conjugated linolenic acidomega 5 conjugated linolenic acid
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)PPARD (Peroxisome proliferator–activated receptor delta)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on punicic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on punicic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call